control group:Huoling Shengji Keli granules simulant 1 bag + riluzole tablets 1 tablet each time, Bid, oral
Sponsors
Peking University Third Hospital
Conditions
Amyotrophic lateral sclerosis
Phase 2
A multicenter, randomized, double-blind, positive drug parallel controlled clinical trial to evaluate the efficacy and safety of Huolingshengji Keli granules for the treatment of amyotrophic lateral sclerosis (ALS).
RecruitingChiCTR2100044085
Start: 2021-03-01Updated: 2021-07-21
A multicenter, randomized, double-blind, positive drug parallel controlled clinical trial to evaluate the efficacy and safety of Huolingshengji Keli granules for the treatment of amyotrophic lateral sclerosis (ALS).
RecruitingITMCTR2100004558
Start: 2021-03-01Updated: 2023-02-20